Narmin Asafovna Orudzhova gynecologist, Center for Gynecology, Oncology, Reproductive and Aesthetic Medicine, MEDSI Clinical Hospital in Otradnoe, Otradnoe, Krasnogorsk, Moscow Region, Russia, e-mail: orudgova.na@medsigroup.ru, https://orcid.org/0009-0002-9022-8684
Dagmara Isaevna Kolgaeva PhD Candidate in Medicine, Center for Gynecology, Oncology, Reproductive and Aesthetic Medicine, MEDSI Clinical Hospital in Otradnoe (Otradnoe, Krasnogorsk, Moscow Region, Russia), associate professor of the Department of Restorative Medicine and Biomedical Technologies, FSBEI HE A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia (Moscow), e-mail: kolgaeva.di@medsigroup.ru, https://orcid.org/0000-0001-5068-5325
Elizaveta Sergeevna Koneva PhD in Medicine, professor of the Department of Sports Medicine and Medical Rehabilitation, I.M. Sechenov First Moscow State Medical University (Sechenov University) (Moscow, Russia), head of the Medical Rehabilitation Center, MEDSI Clinical Hospital in Otradnoe (Otradnoe, Krasnogorsk, Moscow Region, Russia), e-mail: elizaveta.coneva@yandex.ru, https://orcid.org/0000-0002-9859-194X
Ekaterina Nikolaevna Zhumanova PhD in Medicine, head of the Center for Gynecology, Oncology, Reproductive and Aesthetic Medicine, MEDSI Clinical Hospital in Otradnoe (Otradnoe, Krasnogorsk, Moscow Region, Russia), professor of the Department of Restorative Medicine and Biomedical Technologies, FSBEI HE A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia (Moscow, Russian Federation), e-mail: zhumanova.ru@medsigroup.ru, https://orcid.org/0000-0003-3016-4172
Anna Andreevna Mikhailova PhD Candidate in Medicine, associate professor, head of the Scientific and Educational Center, FSBSI Petrovsky National Research Center of Surgery, physiotherapist of the MEDSI Group of Companies, associate professor of the Department of Restorative Medicine and Biomedical Technologies, FSBEI HE A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia, Moscow, e-mail: mikhaylova003@gmail.com, orcid.org/0000-0002-4260-1619, ID RSCI 742373, SPIN code: 7673-3241, Scopus author ID 56002191900
Valeriy Evgenievich Illarionov PhD in Medicine, professor, leading specialist of the Department of Higher and Additional Professional Education and Continuing Medical Education, Research and Educational Center, FSBSI Petrovsky National Research Center of Surgery, Moscow, e-mail: noc@med.ru, ID RSCI 331163, Scopus author ID 7004003488, orcid.org/0000-0001-6416-7836
Vadim Viktorovich Portnov PhD in Medicine, professor, FSBI Central State Medical Academy of the Presidential Administration of the Russian Federation, Moscow, e-mail: vvpphysio@yandex.ru, https:// orcid.org/0000-0003-4515-1219
In patients with cystocele, the effectiveness of conservative therapy is contradictory and does not allow making recommendations for clinical practice. The aim of the study was to evaluate the efficacy of combination therapy for patients with cystocele based on electrical stimulation of the pelvic floor muscles with biofeedback and fractional photothermolysis with a CO₂‑laser, alone or in combination with medications (antimuscarinics and selective β₃‑agonist). The prospective randomized study included 105 patients, of whom 60 had cystocele. The patients were divided into three groups: group 1 included the patients who underwent a course of electrical stimulation of the pelvic floor muscles and photothermolysis (with fractional CO₂ laser) (Physiotherapy group); in group 2, the patients received a combination of physiotherapeutic exposure and pharmacological treatment (Combination group); in group 3, the patients received only pharmacological treatment (Pharmacology group). The stimulation of the pelvic floor muscles was carried out for 10 days, the fractional CO₂‑laser was used 2 times, and pharmacological treatment continued for 3 months. The bladder diary was analyzed. In group 1 there were 25 patients with cystocele, in group 2–10 patients, in group 3–25 patients with cystocele. The indicators of the bladder diary improved significantly in all groups. Increasing the urinary flow rate was more effective with physiotherapy treatment, and reducing the frequency of urination was more efficient with drug therapy. The combination therapy was the most effective. The OAB-q SF score after 3 months may be a predictor of urination frequency less than 8 times per day 6 months after therapy, and the urinary flow rate greater than 14.5 ml / sec before treatment may be a predictor of a high urinary flow rate after 3 months of therapy. Thus, in women with cystocele, the effectiveness of physiotherapy is comparable to drug therapy, and the combination therapy contributes to a better result.